Finn Olav Levy
- Molecular Biology top 5%
- Cellular and Molecular Neuroscience top 2%
- Cardiology and Cardiovascular Medicine top 2%
- Physiology top 5%
- Immunology top 10%
- Co-authors
- Alberto J. KaumannKurt A. KrobertKjetil Wessel AndressenVidar HanssonKjetil TaskénTrond BrattelidLutz BirnbaumerEirik Qvigstad
- Topics
- Receptor Mechanisms and Signaling (57 papers)Cardiac electrophysiology and arrhythmias (24 papers)Phosphodiesterase function and regulation (22 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryThe Journal of Experimental Medicine
- Partner nations
- NorwayUnited StatesUnited Kingdom
In The Last Decade
Finn Olav Levy
129 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 115
- Molecular Biology 2.5k
- Cellular and Molecular Neuroscience 1.1k
- Cardiology and Cardiovascular Medicine 794
- Physiology 382
- Immunology 363
Countries citing papers authored by Finn Olav Levy
This map shows the geographic impact of Finn Olav Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn Olav Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn Olav Levy more than expected).
Fields of papers citing papers by Finn Olav Levy
This network shows the impact of papers produced by Finn Olav Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn Olav Levy. The network helps show where Finn Olav Levy may publish in the future.
Co-authorship network of co-authors of Finn Olav Levy
This figure shows the co-authorship network connecting the top 25 collaborators of Finn Olav Levy. A scholar is included among the top collaborators of Finn Olav Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn Olav Levy. Finn Olav Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 31 | |
| 4 | 15 | |
| 5 | 4 | |
| 6 | 6 | |
| 7 | 0 | |
| 8 | 7 | |
| 9 | 15 | |
| 10 | 19 | |
| 11 | 3 | |
| 12 | 35 | |
| 13 | 21 | |
| 14 | 19 | |
| 15 | Rationale for treatment of heart failure by blockade of ventricular serotonin receptors appearing in heart failure | 1 |
| 16 | 36 | |
| 17 | 139 | |
| 18 | 13 | |
| 19 | 64 | |
| 20 | 1 |
About Finn Olav Levy
Finn Olav Levy is a scholar working on Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience and Molecular Biology, having authored 131 papers that have together received 4.1k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (57 papers), Cardiac electrophysiology and arrhythmias (24 papers) and Phosphodiesterase function and regulation (22 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.1k citations), Molecular Biology (2.5k citations) and Cardiology and Cardiovascular Medicine (794 citations). Finn Olav Levy has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Alberto J. Kaumann, Kurt A. Krobert, Kjetil Wessel Andressen, Vidar Hansson, Kjetil Taskén, Trond Brattelid, Lutz Birnbaumer, Eirik Qvigstad, Knut Martin Torgersen and Tore Jahnsen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.